COVID-19 test kit SMARTCHEK®

pneumoniafor infectious diseaseslead

Real-time PCR based but as fast as rapid test FEATURES Simple workflow for minimized user handling Assay is designed to detect RdRP gene and N gene of SARS-CoV-2 Compact and affordable solution that suits any application 01 Why 2019-nCoV is being an issue throughout the world? First reported from Wuhan, China, on 31 December 2019, 2019-nCoV is the cause of coronavirus disease 2019 (COVID-19) and generally spreads through human-to-human contact or respiratory droplet infection from coughs and sneezes and it is thought to have a zoonotic origin. The symptoms of COVID-19 include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In severe cases, it can lead to pneumonia, severe respiratory acute syndrome, kidney failure and even death. Due to its high contagiousness and severeness, rapid detection of the virus should be performed as quickly as possible for proper medication and treatment. Better detection assay to enhance your testing efficiency Real-time PCR is one of the most well-known methods with good sensitivity and high accuracy for disease diagnostics. However, this technology used to have some disadvantages such as long turn-around-time or complicated workflow. Genesystem is proud to introduce SMARTCHEK® novel coronavirus (SARS-CoV-2) detection kit which is based on biochip sample format and provides relatively short turn-around-time with simple workflow while it offers key benefits of real-time PCR tests.